UBS Group’s Perspective Therapeutics CATX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.28M | Sell |
|
|||||
|
2025
Q1 | $1M | Sell |
|
|||||
|
2024
Q4 | $1.82M | Buy |
|
|||||
|
2024
Q3 | $1.15M | Buy |
|
|||||
|
2024
Q2 | $182K | Buy |
|
|||||
|
2024
Q1 | $10.2K | Sell |
|
|||||
|
2023
Q4 | $7.32K | Buy |
|
|||||
|
2023
Q3 | $186 | Sell |
|
|||||
|
2023
Q2 | $562 | Sell |
|
|||||
|
2023
Q1 | $3.19K | Sell |
|
|||||
|
2022
Q4 | $21.1K | Buy |
|
|||||
|
2022
Q3 | $0 | Sell |
|
|||||
|
2022
Q2 | $5K | Buy |
|
|||||
|
2022
Q1 | $0 | Sell |
|
|||||
|
2021
Q4 | $47K | Buy |
|
|||||
|
2021
Q3 | $26K | Buy |
|
|||||
|
2021
Q2 | $1K | Hold |
|
|||||
|
2021
Q1 | $1K | Sell |
|
|||||
|
2020
Q4 | $22K | Buy |
|
|||||
|
2020
Q3 | $7K | Buy |
|
|||||
|
2020
Q2 | $3K | Sell |
|
|||||
|
2020
Q1 | $22K | Buy |
|
|||||
|
2019
Q4 | $4K | Buy |
|
|||||
|
2019
Q3 | $2K | Buy |
|
|||||
|
2019
Q2 | $0 | Sell |
|
|||||
|
2019
Q1 | $7K | Buy |
|
|||||
|
2018
Q4 | $1K | Sell |
|
|||||
|
2018
Q3 | $6K | Buy |
|
|||||
|
2018
Q2 | $1K | Sell |
|
|||||
|
2018
Q1 | $10K | Sell |
|
|||||
|
2017
Q4 | $17K | Buy |
|
|||||
|
2017
Q3 | $9K | Buy |
|
|||||
|
2017
Q2 | $0 | Hold |
|
|||||
|
2017
Q1 | $0 | Sell |
|
|||||
|
2016
Q4 | $1K | Sell |
|
|||||
|
2016
Q3 | $20K | Buy |
|
|||||
|
2016
Q2 | $4K | Sell |
|
|||||
|
2016
Q1 | $7K | Sell |
|
|||||
|
2015
Q4 | $36K | Buy |
|
|||||
|
2015
Q3 | $12K | Sell |
|
|||||
|
2015
Q2 | $25K | Buy |
|
|||||
|
2015
Q1 | $1K | Buy |
|